Clinical observation on tirofiban in treatment of complex coronary artery lesions with percutaneous ;coronary intervention
HU Xue-hong
LI Yun-tian
LI Jun-xia
TAN Chen
Abstract：Objective To review the efficacy and safety of tirofiban in treatment of complex coronary artery lesions with percutaneous coronary intervention (PCI). Methods The patients with coronary heart disease (CHD) diagnosed as complex coronary artery lesions (n=104, male 56, female 48, aged from 50 to 72 and average age=61.73±6.43) were chosen from Apr. 2013 to Apr. 2014. All patients were randomly divided into control group and intensive group (each n=52). The control group was given PCI and low molecular weight heparin, aspirin, clopidogrel, statins, β-blockers and ACEI, and intensive group was given intravenous injection of tirofiban hydrochloride based on the same therapy and drugs as those in control group. After PCI for 30 d, major adverse cardiovascular events (MACE) were reviewed in 2 groups. The changes of cardiac troponin I (TNI) and high-sensitivity C-reactive protein (hs-CRP) were detected, and incidence of angina attack, bleeding and thrombocytopenia were recorded after PCI. Results The levels of cTnI and hs-CRP were significantly lower in intensive group than those in control group [(0.11±0.05) ng/mL vs. (1.22±0.83) ng/mL, (1.59±0.58) mg/L vs. (5.68±1.34) mg/L, all P<0.01]. There was no MACE in intensive group, and 1 case of unexplained sudden death on the 15th d and 1 case of acute myocardial infarction due to in-stent subacute thrombosis in control group. There were cases of angina pectoris in 2 groups but much less in intensive group than those in control group (1.9%vs. 15.4%, P=0.031). The percentage of patients with grade-3 TIMI was higher in intensive group than that in control group (100%vs. 88.5%) and that with grade-2 TIMI was lower in intensive group than that in control group (0%vs. 11.5%, all P<0.05). In intensive group, 1 case had slight bleeding (petechia) and was relieved after stopping tirofiban, and 2 cases had minor bleed (hematuresis and hemorrhinia). In control group, 2 cases had slight bleeding (conjunctival congestion and gingival bleeding) and 1 case had minor bleeding (bleeding at puncture point). The descend range of hemoglobin was higher in intensive group than that in control group [(1.81±0.565) g/L vs. (1.62±0.530) g/L] without statistical significance (P=0.078). There was only 1 case of mild thrombocytopenia in intensive group. Conclusion Tirofiban hydrochloride has good curative effect and higher safety in treatment of complex coronary artery lesions with PCI.
Keywords：Tirofiban hydrochlorideComplex coronary artery lesionsCoronary intervention treatment
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 313-316 )